Last reviewed · How we verify

phenylmercuric nitrate

unknown active ✓ Verified Jun 2026

phenylmercuric nitrate is a phenylmercuric nitrate drug. It is currently in unknown development for Hemorrhoids, Proctitis, Pruritus ani.

Phenylmercuric nitrate works by releasing mercury ions that have antimicrobial and anti-inflammatory properties.

Phenylmercuric nitrate is a small molecule with antiseptic and antifungal effects, previously used as a topical solution for disinfecting wounds. It is still used in low concentrations as a preservative in eye drops for ophthalmic use.

At a glance

Generic namephenylmercuric nitrate
Drug classphenylmercuric nitrate
Therapeutic areaPain
Phaseunknown

Mechanism of action

Think of it like a strong disinfectant that helps kill bacteria and reduce swelling in the affected area. This can help relieve symptoms like itching, pain, and discomfort. By targeting the root cause of the problem, phenylmercuric nitrate can help promote healing and reduce the risk of infection.

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about phenylmercuric nitrate

What is phenylmercuric nitrate?

phenylmercuric nitrate is a phenylmercuric nitrate drug, indicated for Hemorrhoids, Proctitis, Pruritus ani.

How does phenylmercuric nitrate work?

Phenylmercuric nitrate works by releasing mercury ions that have antimicrobial and anti-inflammatory properties.

What is phenylmercuric nitrate used for?

phenylmercuric nitrate is indicated for Hemorrhoids, Proctitis, Pruritus ani, Rectal pain.

What drug class is phenylmercuric nitrate in?

phenylmercuric nitrate belongs to the phenylmercuric nitrate class. See all phenylmercuric nitrate drugs at /class/phenylmercuric-nitrate.

What development phase is phenylmercuric nitrate in?

phenylmercuric nitrate is in unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing